Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000780967 | SCV000918665 | likely benign | not specified | 2019-08-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001402745 | SCV001604597 | likely benign | RASopathy | 2018-03-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002422671 | SCV002726835 | likely benign | Cardiovascular phenotype | 2021-03-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |